LGG
Clinical trials for LGG explained in plain language.
Never miss a new study
Get alerted when new LGG trials appear
Sign up with your email to follow new studies for LGG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New targeted pill aims to shrink tough tumors with specific genetic flaw
Disease control Recruiting nowThis study is testing an oral drug called plixorafenib (FORE8394) for people with advanced solid tumors or brain tumors that have specific changes in a gene called BRAF. The main goal is to see if the drug can shrink tumors and is safe for patients, including adults and children …
Matched conditions: LGG
Phase: PHASE2 • Sponsor: Fore Biotherapeutics • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New pill combo targets tough cancers in early trial
Disease control Recruiting nowThis early-stage study is testing the safety and initial effects of a new oral medicine, PF-07799544, when taken with another drug, PF-07799933. It is for adults with advanced solid tumors, like melanoma or lung cancer, that have a specific genetic change called a BRAF V600 mutat…
Matched conditions: LGG
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC